Itraconazole
Itraconazole is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Following fungal infections in immunocompromised and non-immunocompromised patients:
- Aspergillosis: treatment in intolerant of or refractory to amphotericin B therapy
- Pulmonary and extrapulmonary blastomycosis
- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated non-meningeal histoplasmosis
- Onychomycosis in non immunocompromised patients (oral capsule):
- Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)
- Onychomycosis of the fingernail due to dermatophytes (tinea unguium).
- Oropharyngeal and esophageal candidiasis (oral liquid)
- Neutropenic fever in pts with a suspected fungal infection (oral liquid).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Coccidioidomycosis
- Cryptococcosis (fluconazole preferred)
- Penicilliosis
- Sporotrichosis
- Candida vaginitis
- Fluconazole-resistant esophageal candidiasis
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
INDICATIONS
FDA
FDA
- Following fungal infections in immunocompromised and non-immunocompromised patients:
- Aspergillosis: treatment in intolerant of or refractory to amphotericin B therapy
- Pulmonary and extrapulmonary blastomycosis
- Histoplasmosis, including chronic cavitary pulmonary disease and disseminated non-meningeal histoplasmosis
- Onychomycosis in non immunocompromised patients (oral capsule):
- Onychomycosis of the toenail, with or without fingernail involvement, due to dermatophytes (tinea unguium)
- Onychomycosis of the fingernail due to dermatophytes (tinea unguium).
- Oropharyngeal and esophageal candidiasis (oral liquid)
- Neutropenic fever in pts with a suspected fungal infection (oral liquid).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Coccidioidomycosis
- Cryptococcosis (fluconazole preferred)
- Penicilliosis
- Sporotrichosis
- Candida vaginitis
- Fluconazole-resistant esophageal candidiasis
There's more to see -- the rest of this entry is available only to subscribers.